This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient with Parkinson's disease has been achieving effective symptom control with levodopa ... (Read 26 times)

dalyningkenk

  • Hero Member
  • *****
  • Posts: 598
on: Jul 23, 2018
A patient with Parkinson's disease has been achieving effective symptom control with levodopa (Dopar) but complains that the symptoms begin to return before it is time for the next dose. The drug just wears off, he states.
 
  The nurse should anticipate that the prescriber will order the pa-tient to a. take the levodopa at shorter dosing intervals.
  b. start taking a drug that reduces levodopa's half-life.
  c. take levodopa at longer dosing intervals.
  d. increase the dose to increase receptor binding.

Question 2

An obese patient is admitted to the unit. The blood glucose level is 379, urinalysis reveals glycosuria, blood pressure is 178/99, and the patient complains of muscle aches and weakness.
 
  The patient also exhibits a moon face and buffalo hump. The nurse recognizes these signs and symptoms as ___________________ ___ and anticipates ___________________ __. a. Graves' disease; treatment directed at the cause
  b. Addison's disease; administration of fludrocortisone
  c. Cushing's syndrome; treatment directed at the cause
  d. diabetes; insulin replacement therapy


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Dnite

  • Sr. Member
  • ****
  • Posts: 297
Reply #1 on: Jul 23, 2018
Answer to Question 1

A
Gradual loss (wearing off) develops near the end of the dosing interval and simply indicates that drug levels have declined to a subtherapeutic value. Wearing off can be minimized by shortening the dosing interval.
Giving a drug that prolongs levodopa's plasma half-life and giving a direct-acting dopamine agonist would be effective; giving a drug that reduces levodopa's half-life would not.
Levodopa should be taken at shorter dosing intervals, not longer ones.
Increasing the dose does not increase receptor binding. The availability of receptor binding makes a difference, and as does the drug's affinity for the receptor.

Answer to Question 2

C
Cushing's syndrome is manifested by obesity, hyperglycemia, glycosuria, hypertension, fluid and electrolyte disturbances, osteoporosis, muscle weakness, myopathy, hirsutism, a moon face, and a buffalo hump. Treatment is directed at the cause.
Graves' disease is not associated with the adrenal gland, but rather with the thyroid gland.
Addison's disease is manifested by weakness, emaciation, hypoglycemia, and increased pigmen-tation of the skin and mucous membranes.
Diabetes is manifested in many ways but not by a moon face or buffalo hump.


dalyningkenk

  • Member
  • Posts: 598
Reply 2 on: Jul 23, 2018
Gracias!

skipfourms123

  • Member
  • Posts: 343
Reply 3 on: Yesterday
Wow, this really help

« previous next »
 

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

An example of a homeostatic control system. An example of a homeostatic control system.
The tone of the nurse-patient introduction sets the stage for the patient interview and patient care The tone of the nurse-patient introduction sets the stage for the patient interview and patient care
Taking a Patient’s Temperature with a Tympanic Thermometer Taking a Patient’s Temperature with a Tympanic Thermometer
A histologic slide showing the sponge-like architecture of a patient with Creutzfeldt-Jakob Disease. A histologic slide showing the sponge-like architecture of a patient with Creutzfeldt-Jakob Disease.
The vehicle emissions control information (VECI) sticker is placed under the hood. The vehicle emissions control information (VECI) sticker is placed under the hood.
Risk assessment codes for an HIV-infected patient. Risk assessment codes for an HIV-infected patient.
Video: Nerve Impulse Transmission Animation

For a complete list of videos, visit our video library